ArticleDrug design, development and therapy2018

Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors.

Keivan Sadrerafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.